Btla

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

B and T lymphocyte associated; B and T lymphocyte attenuator; BTLA1; CD272

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

BTLA, the acronym for "B and T lymphocyte associated" also known as "B and T lymphocyte matenuator", is a protein belonging to the family of anti-inflammatory immune checkpoints (ICs).

General informationThis section has been translated automatically.

Anti-inflammatory immune checkpoints inhibit the immune reactivity of T lymphocytes, in contrast to pro-inflammatory ICs, which increase the immune reactivity of T lymphocytes. The immune checkpoints are activated by precisely fitting cytokines (ligands) that are presented and released by other cells.

In humans, the BTLA protein is encoded by the BTLA gene. It contains a single immunoglobulin domain and serves as a receptor that suppresses immunological reactions. The BTLA protein is a target for new anticarcinogenic therapy modalities (Torphy RJ et al. 2017)

LiteratureThis section has been translated automatically.

  1. Torphy RJ et al (2017) Newly Emerging Immune Checkpoints: Promises for Future Cancer Therapy. Int J Mol Sci 18. pii: E2642.
  2. Ye Z et al (2016) Decreased B and T lymphocyte attenuator in Behcet's disease may trigger abnormal Th17 and Th1 immune responses. Sci Rep 6:20401.

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer